[Partial purification and characterization of interferon from mouse brain].

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 5679338)

Published in Ann Inst Pasteur (Paris) on August 01, 1968

Authors

R Falcoff, D Fontaine-Brouty, E Falcoff

Articles by these authors

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med (1990) 2.67

Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells. J Virol (1973) 2.00

Regulation of human gamma-interferon and beta-interferon gene expression in PHA-activated lymphocytes. J Interferon Res (1986) 1.81

Suppression of human interferon production by inhibitors of glycosylation. Virology (1975) 1.69

Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur J Immunol (1984) 1.58

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand (1988) 1.57

Effect of repeated inoculation of interferon preparations on infection of mice with encephalomyocarditis virus. Proc Soc Exp Biol Med (1968) 1.53

Physico-chemical characterization and partial purification of mouse immune interferon. J Gen Virol (1979) 1.49

Interferon and murine leukemia. I. Inhibitory effect of interferon preparations on development of friend leukemia in mice. Proc Soc Exp Biol Med (1967) 1.43

Yeast tRNALeu (anticodon U--A--G) translates all six leucine codons in extracts from interferon treated cells. FEBS Lett (1977) 1.41

Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells. Virology (1980) 1.31

Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis (1991) 1.29

125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data. J Gen Virol (1985) 1.20

Some properties of virus and immune-induced human lymphocyte interferons. J Gen Virol (1972) 1.20

[Estimation of the molecular weight of the interferon produced by human leukocytes]. C R Acad Sci Hebd Seances Acad Sci D (1965) 1.19

Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J Interferon Res (1985) 1.16

Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever. J Infect Dis (1992) 1.13

[Biologic activity of human interferon on the simian species in vitro and in vivo]. C R Acad Sci Hebd Seances Acad Sci D (1968) 1.12

[Comparative study of the molecular weights of 2 human interferons produced in vitro]. Ann Inst Pasteur (Paris) (1966) 1.09

Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons. Antiviral Res (1982) 1.07

Endogenous interferon in Argentine hemorrhagic fever. J Infect Dis (1984) 1.05

Translation of mRNA from phytohemagglutinin-stimulated human lymphocytes: characterization of interferon mRNAs. J Interferon Res (1982) 1.05

Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells. Proc Natl Acad Sci U S A (1980) 1.04

Dual action of double-stranded RNA inhibiting protein synthesis in extracts of interferon-treated mouse L cells. Translation is impaired at the level of initiation and by mRNA degradation. Eur J Biochem (1978) 1.03

Interferon and murine leukemia. V. Effect of interferon preparations on the evolution of Rauscher disease in mice. J Natl Cancer Inst (1968) 1.02

Production of antibodies against mouse immune T (type II) interferon and their neutralizing properties. J Gen Virol (1980) 1.01

A comparison of the translation of Mengo virus RNA and globin mRNA in krebs ascites cell-free extracts. FEBS Lett (1972) 1.00

Interferon treatment inhibits Mengo RNA and haemoglobin mRNA translation in cell-free extracts of L cells. Nat New Biol (1972) 0.97

Interferon induction by Lactobacillus bulgaricus and Streptococcus thermophilus in mice. Eur Cytokine Netw (1992) 0.96

Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation. J Immunol (1986) 0.95

Kinetics of messenger accumulation coding for IFN gamma, related to modifications in the poly(A) RNA population of activated human lymphocytes. Nucleic Acids Res (1984) 0.94

Affinity chromatographic analysis of murine interferons induced by viruses and by T and B cell stimulants. Ann Immunol (Paris) (1977) 0.94

Influence of preincubation on the development of the inhibition of protein synthesis in extracts from interferon-treated mouse L cells. Action on tRNA. Virology (1978) 0.94

Interferon-beta 2 (BSF-2) mRNA is expressed in human monocytes. J Interferon Res (1988) 0.93

Lymphocyte stimulation and interferon induction by 7 S anti-human lymphocyte globulins and their uni- and divalent fragments. Eur J Immunol (1972) 0.93

Enhancement of mouse natural killer cell activity by type II interferon. Ann Immunol (Paris) (1980) 0.93

Interferon and murine leukemia. II. Factors related to the inhibitory effect of interferon preparations on development of Friend leukemia in mice. Proc Soc Exp Biol Med (1967) 0.91

Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors. Eur J Cancer Clin Oncol (1982) 0.90

Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients. Eur J Cancer Clin Oncol (1982) 0.90

In vivo protective effect of the lectin from Canavalia brasiliensis on BALB/c mice infected by Leishmania amazonensis. Acta Trop (1996) 0.90

T-cell surface antigens defined by monoclonal antibodies, involved in the induction of human interferon-gamma and interleukin 2. Cell Immunol (1985) 0.89

Some properties of interferons induced by stimulants of T and B lymphocytes. Tex Rep Biol Med (1977) 0.89

[Human interferons induced in vitro by synthetic polynucleotides]. Biochim Biophys Acta (1969) 0.88

Synthesis of interferon in human lymphocytes stimulated "in vitro" by antilymphocytic serum. Rev Eur Etud Clin Biol (1972) 0.88

Intracellular human gamma-interferon triggers an antiviral state in transformed murine L cells. Proc Natl Acad Sci U S A (1987) 0.87

Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells. Blood (1986) 0.86

Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia. Blood (1989) 0.85

[Induction of human interferon by antilymphocyte serum]. C R Acad Sci Hebd Seances Acad Sci D (1970) 0.85

Demonstration, mass production and characterization of a heavy molecular weight human interferon. J Immunol (1967) 0.85

Immune interferon induced by phytohemagglutinin in nude mouse spleen cells. Infect Immun (1978) 0.85

Interferon and murine leukaemia. 3. Efficacy of interferon preparations administered after inoculation of Friend virus. Nature (1967) 0.85

Action of murine gamma (immune)interferon on beta (fibroblast)-interferon resistant L 1210 and embryonal carcinoma cells. J Interferon Res (1980) 0.85

Properties of mouse immune T-interferon (type II). Ann N Y Acad Sci (1980) 0.84

Presence of a polynucleotide binding site on murine immune interferon (T-type). Biochem Biophys Res Commun (1978) 0.84

[Interferon-inducing capacity of double-stranded RNA. II. Studies on Mengo virus replicatative intermediate]. Biochim Biophys Acta (1970) 0.83

Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-gamma. J Immunol (1987) 0.83

An improved methodology for preparation of virus-induced double stranded RNA. Biochimie (1973) 0.82

Acute and chronic experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon-gamma. Microbiol Immunol (1995) 0.82

Studies on purification of human gamma interferon: chromatographic behavior of accompanying IL2 and B-cell helper activity. J Interferon Res (1984) 0.82

Inhibition of steroid inducible tyrosine aminotransferase by mouse and rat interferon in hepatoma tissue culture cells. FEBS Lett (1974) 0.82

Serum interferon activity of patients with leishmaniasis. Braz J Med Biol Res (1989) 0.81

Secretion of interleukin-6 (IL-6) by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha. Immunology (1990) 0.81

Inhibitory effect of interferon on DNA and RNA synthesis in murine spleen cells stimulated by lectins. Ann Immunol (Paris) (1976) 0.81

Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma. Leukemia (1987) 0.81

Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment. Blood (1986) 0.81

Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma. Cancer (1986) 0.80

Recombinant human interferon-gamma inhibits adenovirus multiplication in vitro. J Gen Virol (1987) 0.80

Synergistic effect of interferon-gamma and tumor necrosis factor-alpha on antiviral activity and (2'-5') oligo (A) synthetase induction in a myelomonocytic cell line. J Leukoc Biol (1990) 0.79

General procedures for purification of mouse immune interferon. Methods Enzymol (1981) 0.79

Activity of a platelet protein kinase that phosphorylates fibrinogen and histone in Argentine hemorrhagic fever. Acta Physiol Pharmacol Ther Latinoam (1991) 0.79

Double-stranded ribonucleic acid from Mengo virus: production, characterization, and interferon-inducing and antiviral activities in comparison with polyriboinosinic-polyribocytidylic acid. Antimicrob Agents Chemother (1973) 0.79

Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients. Cancer Res (1981) 0.79

[Induction of interferon synthesis by double-stranded RNA. I. Application to the study of the multiplication cycle of Mengo virus]. Biochim Biophys Acta (1969) 0.79

The use of a complementary DNA probe to detect accumulation of mengo RNA in infected cells pretreated with interferon. Biochimie (1977) 0.79

Chromatographic behavior, purification, and properties of mouse BCG-induced gamma interferon. J Interferon Res (1982) 0.79

The effector function of platelets is induced and regulated by T lymphocytes. Ann Inst Pasteur Immunol (1988) 0.79

Interferon induction by and infectivity of ultraviolet-irradiated double- and multistranded viral RNA's. Biochim Biophys Acta (1970) 0.78

SLO4, a new interferon inducer isolated from Klebsiella pneumoniae and Escherichia coli. J Immunopharmacol (1985) 0.78